UCB S.A.
Patent Owner
Stats
- 9 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 23, 2011 most recent publication
Details
- 9 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,869 Total Citation Count
- Mar 10, 1977 Earliest Filing
- 119 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6124473 Process for preparing (s)- and (R)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamideMay 07, 99Sep 26, 00[C07D]
6066232 Method and vaporizer for vaporizing oxidation-sensitive compoundsJul 24, 98May 23, 00[C07C, B01D]
5478941 Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazineMar 08, 94Dec 26, 95[C07D]
5447952 Treatment of anxiety with the aid of (S)-(-)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamideSep 20, 94Sep 05, 95[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0150,866 Compositions and Methods for Increasing Bone MineralizationAbandonedOct 31, 07Jun 23, 11[A61K, A61P]
2011/0027,359 Novel Pharmaceutical Compositions Comprising LevetiracetamAbandonedMar 10, 10Feb 03, 11[A61K, C07D, A61P]
2010/0063,105 PHARMACEUTICAL USES AND SYNTHESIS OF NICOTINANILIDE-N-OXIDESAbandonedOct 18, 06Mar 11, 10[A61K, C07D, G01N, A61P]
7622278 Compositions and methods for diagnosing or treating psoriasisExpiredJul 09, 08Nov 24, 09[C12N]
2009/0169,543 Method for regulating immune function in primates using the Foxp3 proteinAbandonedNov 06, 08Jul 02, 09[A61K, C12Q, A61P, C07K]
7544675 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositionsExpiredMar 29, 03Jun 09, 09[A61K, C07D]
7507542 Method for regulating immune function using the FOXP3 proteinExpiredMay 08, 02Mar 24, 09[G01N]
7473697 2-Oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disordersExpiredJun 15, 06Jan 06, 09[A61K]
7465549 Methods for identifying agents that bind a levetiracetam binding site (LBS) or compete with LEV binding to a LBS of a synaptic vesicle protein 2 (SV2)ExpiredDec 02, 03Dec 16, 08[G01N]
2008/0131,411 Identification of the gene causing the mouse scurfy phenotype and its human orthologAbandonedApr 16, 07Jun 05, 08[A61K, A61P]
7381821 Piperazine derivatives and their use as synthesis intermediatesExpiredJan 20, 04Jun 03, 08[C07D]
7361668 Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitorsExpiredSep 23, 02Apr 22, 08[A61K]
2007/0185,122 Use of efletirizine for treating persistent allergic rhinitisAbandonedMay 24, 04Aug 09, 07[A61K]
2007/0135,514 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseasesAbandonedDec 02, 03Jun 14, 07[A61K]
7220579 Identification of the gene causing the mouse scurfy phenotype and its human orthologExpiredNov 15, 04May 22, 07[C12N]
7176310 Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agentsExpiredApr 04, 03Feb 13, 07[C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.